FRANKFURT, Germany (AP) — Danish pharmaceutical company Novo Nordisk, maker of weight-loss drug Wegovy, said Wednesday it would cut 9,000 jobs, 5,000 of them in Denmark, in order to strengthen the company’s focus on growth opportunities in obesity and diabetes medications.

Related Articles

Trump’s Federal Reserve board nominee is approved by Senate committee

Wall Street ticks toward more records as inflation slows and Oracle soars

U.S. producer prices unexpectedly fell 0.1% in August

Belmont Park kicks off Family Fun Fridays, with free food and BOGO rides

Brigantine proposing $26M redevelopment of Fish Market restaurant on San Diego Bay

The restructuring, which would eliminate 11% of the company’s workforce, aimed to reduce organizational complexity and speed up decision-making as t

See Full Page